• Vol. 40 No. 7, 304–306
  • 15 July 2011

Alzheimer’s Disease: Clinical Trials and the Amyloid Hypothesis

139



139 Views
21 Downloads

Download PDF

Alzheimer’s disease (AD) is a progressive fatal neurodegenerative disease whose numbers are approaching epidemic proportions as the world’s population ages. There are currently 35 million victims worldwide with an anticipated 115 million by 2050 if effective treatments are not found. There is an urgent need to identify treatments that will prevent or delay the onset, slow the progression, or improve the symptoms of AD and related neurodegenerative disorders affecting cognition and survival in the elderly.

This article is available only as a PDF. Please click on “Download PDF” on top to view the full article.